Navigation Links
Weikang Bio-Technology Reports Second Quarter 2010 Financial Results
Date:8/16/2010

at are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

--FINANCIAL TABLES FOLLOW-- WEIKANG BIO-TECHNOLOGY GROUP CO, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS 30-Jun-10 31-Dec-09 (Unaudited) ASSETS CURRENT ASSETS Cash & cash equivalents $20,485,278 $11,380,019 Advances to suppliers and other receivables 150,537 26,079 Inventory 1,045,905 285,395 Deferred tax asset 132,788 -- Total current assets 21,814,508 11,691,493 NONCURRENT ASSETS Property and equipment, net 9,768,826 10,162,946 Construction in progress 446,823 -- Intangible assets 15,500,960 15,558,731 Total noncurrent assets 25,716,609 25,721,677 TOTAL ASSETS $47,531,117 $37,413,170 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $13,669 $12,668 Unearned revenue -- 11,716 Taxes payable 1,522,402 2,247,410 Due to related party 25,034 -- Total current liabilities 1,561,105 2,271,794 ADVANCE FORM OFFICER 650,000 650,000 OTHER PAYABLES 7,720,321 7,620,321 CONTINGENCIES DEFERRED TAX LIABILITY 3,421,953 3,450,005 STOCKHOLDERS' EQUITY Common stock, $.00001 par value; authorized shares 100,000,000; issued and outstanding shares 28,024,388 and 25,486,800 at June 30, 2010 and December 31, 2009, respectively 280 255 Additional paid in capital 4,967,720 139,245 Deferred compensation (753,306) -- Statutory reserve 1,404,276 1,069,507 Accumulated other comprehensive income 1,067,168 844,526 Retained earnings 27,491,600 21,367,517 Total stockholders' equity 34,177,738 23,421,050 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $47,531,117 $37,413,170 WEIKANG BIO-TECHNOLOGY GROUP CO, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS
'/>"/>

SOURCE Weikang Bio-Technology Group Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
2. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
3. Par Pharmaceutical Reports Second Quarter 2008 Results
4. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
5. Pharmos Corporation Reports 2008 Second Quarter Results
6. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
7. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
8. BMP Sunstone Reports Second Quarter 2008 Financial Results
9. ULURU Inc. Reports Second Quarter 2008 Financial Results
10. Immtech Reports Fiscal First Quarter 2009 Results
11. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
(Date:1/14/2014)... 2014  3D Communications, a leading provider of strategic communications services to ... events in the United States and ... Cox , JD, is returning to the firm,s Washington, ... 3D after more than two years of service as Associate Commissioner ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Estate Equities, Inc. (NYSE: ARE ), Landlord of ... , today provided an update highlighting recent accomplishments. , ... Pfizer Inc. at the Alexandria Center for Science and ... Pfizer Inc. entered into a 15-year lease for approximately ...
... Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 8th ... a.m. Pacific Time. , The conference is being held October 28-29, 2009, at ... with slides and available for replay afterwards. The webcast can be accessed at ... ...
... Ind., Oct. 28 Zimmer Holdings, Inc. (NYSE: ... Grants Association LLC (OMeGA) has chosen its 2009 grant ... administrator for graduate medical education to which Zimmer committed ... 2009-2010 academic year. , OMeGA received more than 250 ...
Cached Biology Technology:Alexandria Real Estate Equities, Inc. Provides Update 2Alexandria Real Estate Equities, Inc. Provides Update 3Alexandria Real Estate Equities, Inc. Provides Update 4Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 2Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 4
(Date:4/24/2014)... Researchers from North Carolina State University and the University ... new ultrasound device that could help identify arterial plaque ... causing heart attack or stroke. , At issue is ... age. Some types of plaque are deemed "vulnerable," meaning ... artery wall and cause heart attack or stroke. , ...
(Date:4/24/2014)... of clear liquid can bend light, acting as a ... developed a new process to create inexpensive high quality ... , Because they,re so inexpensive, the lenses can ... to detect diseases in the field, scientific research in ... in classrooms. , "What I,m really excited about ...
(Date:4/23/2014)... chronic inflammatory disorders among people of lower socioeconomic status ... to the microbes that thrive in rural environments, according ... in the journal Clinical & Experimental Immunology , ... less access to green spaces may be more apt ... system dysfunction. , When our immune systems are working ...
Breaking Biology News(10 mins):New ultrasound device may add in detecting risk for heart attack, stroke 2Bake your own droplet lens 2Bake your own droplet lens 3Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3
... to over hunting in the 19th century, wild elk ... of the Ontario elk restoration program. According to a ... issue of Restoration Ecology, 460 elk were brought from ... and 2001. , "The Ontario elk restoration program has ...
... Researchers at the University of Illinois at Urbana-Champaign ... optical microscopy that can produce crisp, three-dimensional images ... Aperture Microscopy, ISAM can do for optical microscopy ... resonance, and what computed tomography did for X-ray ...
... gene has been discovered by scientists at the Lundberg Laboratory ... Sahlgrenska Academy in Sweden. The researchers found that women with ... higher risk of contracting breast cancer than expected. , ... for new hereditary breast cancer genes, but thus far few ...
Cached Biology News:Novel computed imaging technique uses blurry images to enhance view 2New hereditary breast cancer gene discovered 2
... Kit uses a simplified procedure and streamlines ... The kit is based on the three ... and sodium bisulfite where cytosine is converted ... innovative in-column desulphonation reaction eliminates several precipitation ...
... The DIGIVIEW line of digital x-ray ... radiation imaging device complete with 12 to ... area consists of a photodiode array sensor ... All models are available in low x-ray ...
Metamine is an autonomous data mining tool that extends the capabilities of conventional research teams. It is a proactive agent that searches for significant results buried within the GeNet data rep...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selecitivty and potential CNS-Side Effect liabilities of compo...
Biology Products: